| Dissecting the oncogenic potential of Gli2: deletion of an NH(2)-terminal fragment alters skin tumor phenotype. | skin, |
| Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells. | liver,glioma, |
| Nuclear accumulation of glioma-associated oncogene 2 protein and enhanced expression of forkhead-box transcription factor M1 protein in human hepatocellular carcinoma. | liver,glioma, |
| Expression of glioma-associated oncogene 2 (Gli 2) is correlated with poor prognosis in patients with hepatocellular carcinoma undergoing hepatectomy. | liver,glioma, |
| DeltaNp63alpha enhances the oncogenic phenotype of osteosarcoma cells by inducing the expression of GLI2. | osteosarcoma, |
| Gip-2 codon 179 oncogene mutations: absent in adrenal cortical tumors. | kidney, |
| Cloning of novel isoforms of the human Gli2 oncogene and their activities to enhance tax-dependent transcription of the human T-cell leukemia virus type 1 genome. | leukemia, |
| Expression of the GLI2 oncogene and its isoforms in human basal cell carcinoma. | None |
| The stroma, in a tissue-specific manner, determines whether certain GLI2 oncogenic traits are expressed. | None |
| Stromal control of oncogenic traits expressed in response to the overexpression of GLI2, a pleiotropic oncogene. | None |